Chronic
Financial Hardship, Healthcare Utilization, and Health Among U.S. Cancer Survivors
This study examined associations of both medical and nonmedical financial hardships with healthcare utilization and self-rated health among cancer survivors.Patient–Provider Discussions About Out-of-Pocket Costs of Cancer Care in the U.S.
Despite the importance of cost-related discussions in cancer care, little is known about the prevalence or drivers of these discussions in clinical practice. This study estimates the prevalence and examines the correlates of cancer survivors’ discussions about out-of-pocket costs of cancer care with providers.Changes in Breast and Colorectal Cancer Screening After Medicaid Expansion Under the Affordable Care Act
Medicaid expansions following the Affordable Care Act have improved insurance coverage in low-income adults, but little is known about its impact on cancer screening. This study examined associations between Medicaid expansion timing and colorectal cancer (CRC) and breast cancer (BC) screening.Healthcare Expenditure Burden Among Non-elderly Cancer Survivors, 2008–2012
There is increasing concern regarding the financial burden of cancer on patients and their families. This study presents nationally representative estimates of annual out-of-pocket (OOP) burden among non-elderly cancer survivors and assesses the association between high OOP burden and access to care and preventive service utilization.Prevalence and Costs of Skin Cancer Treatment in the U.S., 2002−2006 and 2007−2011
Skin cancer, the most common cancer in the U.S., is a major public health problem. The incidence of nonmelanoma and melanoma skin cancer is increasing; however, little is known about the economic burden of treatment.Productivity Savings from Colorectal Cancer Prevention and Control Strategies
Lost productivity represents a considerable portion of the total economic burden of colorectal cancer (CRC), but cost-effectiveness studies of CRC prevention and control have not included these costs and therefore underestimate potential savings from CRC prevention and control.
